The status of paediatric medicines initiatives around the world-what has happened and what has not?

K Hoppu, G Anabwani, F Garcia-Bournissen, M Gazarian, GL Kearns, H Nakamura, RG Peterson, SS Ranganathan, Saskia de Wildt

Research output: Contribution to journalArticleAcademicpeer-review

75 Citations (Scopus)

Abstract

Purpose This review was conducted to examine the current status of paediatric medicines initiatives across the globe. Methods The authors made a non-systematic descriptive review of current world situation. Results Two regions, the United States (US) and the European Union (EU), and the World Health Organization (WHO) have introduced strong paediatric initiatives to improve children's health through improving access to better paediatric medicines. The experience from the US initiative indicates that it is possible to stimulate development and study of paediatric medicines and provide important new information for improvement of paediatric therapy. The early results from the EU initiative are simila Conclusions Although much still needs to be done, it's clear that with concerted efforts and appropriate resources, change is possible but slow. Retaining and fostering public and political interest in paediatric medicines is challenging, but pivotal for success.
Original languageUndefined/Unknown
Pages (from-to)1-10
Number of pages10
JournalEuropean Journal of Clinical Pharmacology
Volume68
Issue number1
DOIs
Publication statusPublished - 2012

Research programs

  • EMC MGC-02-53-01-A

Cite this